BSEAmerise Biosciences LtdMinimalNeutral
Announced Wed, 22 Apr · 16:37 IST

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹0.74
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-4.1-8.1-4.1-6.8-4.1+0.0-4.1+16.2+18.9
Up moveDown movePending
AI summary

This filing relates to a mandatory initial disclosure requirement for entities identified as 'Large Corporates' under SEBI regulations. However, the actual document content provided appears to be a BSE error page ('The Page you are looking for has been moved') rather than the substantive filing data. The disclosure is part of SEBI's framework requiring large listed entities to make periodic disclosures regarding their borrowings and debt securities. Without access to the actual disclosure details, specific figures or compliance status cannot be confirmed.

Likely market impact

This appears to be a routine regulatory compliance filing. No specific impact on stock price can be determined from the available information. Investors should monitor for corrected or re-filed documents with actual disclosure data.